Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 9.6 mg (equivalent: rivastigmine, qty 6 mg) - capsule, hard - excipient ingredients: iron oxide red; hypromellose; gelatin; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; magnesium stearate; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; potassium hydroxide; ammonia; pharmaceutical glaze - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 4.8 mg (equivalent: rivastigmine, qty 3 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; hypromellose; magnesium stearate; titanium dioxide; iron oxide red; iron oxide yellow; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; potassium hydroxide; ammonia; pharmaceutical glaze - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg (equivalent: rivastigmine, qty 1.5 mg) - capsule, hard - excipient ingredients: gelatin; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; iron oxide red; ethanol absolute; potassium hydroxide; ammonia; pharmaceutical glaze - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

nia pharmaceuticals pty ltd - 44237 - lubricant, eye - ophthalmic solution moisturizing, lubricating and refreshing particularly suitable for dry eyes and improving the comfort of contact lenses worn. indications: lubricating, moisturizing and refreshing; ideal in case of non-traumatic/non-pathological alterations of the tear film; environmental ocular stress (wind, dust, air conditioning, dry and polluted air, etc.); ocular stress (extended computer use, unfavourable lighting conditions, night driving etc.); indicated in case of extended use of contact lenses; indicated to improve the comfort of the worn contact lenses and reduce fogging; indicated for the prevention of the dirt deposits and the dehydration of the lens; indicated to be used also with contact lenses worn; eliminate the device according to the current legislation

Malta - English - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - pantoprazole - gastro-resistant tablet - pantoprazole 20 mg - drugs for acid related disorders

Malta - English - Medicines Authority

cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - oxidronate sodium - kit for radiopharmaceutical preparation - oxidronate sodium 3 mg - diagnostic radiopharmaceuticals

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - n - kit for radiopharmaceutical preparation - n-[2,4,6-trimethyl-3-bromacetanilid] iminodiacetic acid sodium salt 20 mg - diagnostic radiopharmaceuticals

Malta - English - Medicines Authority

ge healthcare s.r.l. via galeno 36, 20126, milan, italy - human albumin, colloidal particles - kit for radiopharmaceutical preparation powder for solution for injection - human albumin colloidal particles 500 µg - diagnostic radiopharmaceuticals

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - human serum, albumin - kit for radiopharmaceutical preparation - human serum albumin 500 µg - diagnostic radiopharmaceuticals

Israel - English - Ministry of Health

vertex pharmaceuticals (u.k) limited, israel - ivacaftor; lumacaftor - film coated tablets - ivacaftor 125 mg; lumacaftor 100 mg - ivacaftor and lumacaftor - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who are homozygous for the f508del mutation in the cftr gene limitations of use the efficacy and safety of orkambi have not been established in patients with cf other than those homozygous for the f508del mutation